Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix/Influsplit SSW 2012/2013 in People Aged 18 Years and Above

NCT01607112 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01607112
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01607112 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Study for Evaluation of Immunogenicity and Reactogenicity of Fluarix/Influsplit SSW 2012/2013 in People Aged 18 Years and Above
Lead sponsor
GlaxoSmithKline
Phase
Phase 3
Overall status
Completed
Start date
July 10, 2012
Completion date
July 31, 2012
Enrollment
119 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

influenza